The role of cytokines in the establishment, persistence and eradication of the HIV reservoir
- PMID: 22743037
- PMCID: PMC3767481
- DOI: 10.1016/j.cytogfr.2012.05.001
The role of cytokines in the establishment, persistence and eradication of the HIV reservoir
Abstract
HIV persists in cellular and anatomical reservoirs during Highly Active Antiretroviral Therapy (HAART). In vitro studies as well as in vivo observations have identified cytokines as important factors regulating the immunological and virological mechanisms involved in HIV persistence. Immunosuppressive cytokines might contribute to the establishment of viral latency by dampening T cell activation and HIV production, thereby creating the necessary immuno-virological condition for the establishment of a pool of latently infected cells. Other cytokines that are involved in the maintenance of memory CD4(+) T cells promote the persistence of these cells during HAART. Conversely, proinflammatory cytokines may favor HIV persistence by exacerbating low levels of ongoing viral replication in lymphoid tissues even after prolonged therapy. The ability of several cytokines to interfere with the molecular mechanisms responsible for HIV latency makes them attractive candidates for therapeutic strategies aimed at reducing the pool of latently infected cells. In this article, we review the role of cytokines in HIV persistence during HAART and discuss their role as potential eradicating agents.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures


Similar articles
-
The challenge of viral reservoirs in HIV-1 infection.Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024. Annu Rev Med. 2002. PMID: 11818490 Review.
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.PLoS Pathog. 2007 Aug 31;3(8):e122. doi: 10.1371/journal.ppat.0030122. PLoS Pathog. 2007. PMID: 17784786 Free PMC article.
-
The development of immune-modulating compounds to disrupt HIV latency.Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):159-72. doi: 10.1016/j.cytogfr.2012.05.003. Epub 2012 Jul 4. Cytokine Growth Factor Rev. 2012. PMID: 22766356 Review.
-
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.J Virol. 2010 Mar;84(6):2913-22. doi: 10.1128/JVI.02356-09. Epub 2009 Dec 23. J Virol. 2010. PMID: 20032180 Free PMC article.
Cited by
-
Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.Retrovirology. 2013 Feb 1;10:11. doi: 10.1186/1742-4690-10-11. Retrovirology. 2013. PMID: 23375003 Free PMC article. Review.
-
The reservoir of latent HIV.Front Cell Infect Microbiol. 2022 Jul 28;12:945956. doi: 10.3389/fcimb.2022.945956. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35967854 Free PMC article. Review.
-
A cure for AIDS: a matter of timing?Retrovirology. 2013 Nov 22;10:145. doi: 10.1186/1742-4690-10-145. Retrovirology. 2013. PMID: 24267982 Free PMC article. Review.
-
Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.Biochem Pharmacol. 2022 Jan;195:114844. doi: 10.1016/j.bcp.2021.114844. Epub 2021 Nov 18. Biochem Pharmacol. 2022. PMID: 34801521 Free PMC article.
-
HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.Viruses. 2014 Apr 14;6(4):1715-58. doi: 10.3390/v6041715. Viruses. 2014. PMID: 24736215 Free PMC article. Review.
References
-
- Clerici M. Beyond IL-17: new cytokines in the pathogenesis of HIV infection. Current Opinion in HIV and AIDS. 2010;5:184–188. - PubMed
-
- Carr A, Amin J. Efficacy and tolerability of initial antiretroviral therapy: a systematic review. AIDS. 2009;23:343–353. discussion 355–356. - PubMed
-
- Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323:1304–1307. - PubMed
-
- Trono D, Van Lint C, Rouzioux C, Verdin E, Barre-Sinoussi F, Chun TW, et al. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science. 2010;329:174–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials